Medipal Holdings Corporation Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2017; Reaffirms Consolidated Earnings Guidance for the Year Ending March 31, 2018
February 06, 2018
Share
MediPal Holdings Corporation reported consolidated earnings results for the nine months ended December 31, 2017. For the quarter, the company's net sales were JPY 2,390.4 billion compared to JPY 2,329.6 billion a year ago. Operating profit was JPY 34.1 billion compared to JPY 32.8 billion a year ago. Ordinary profit was JPY 44.1 billion compared to JPY 43.1 billion a year ago. Profit attributable to owners of parent was JPY 27.7 billion compared to JPY 23.5 billion a year ago.
The company reaffirmed consolidated earnings guidance for the year ending March 31, 2018. For the period, the company expects net sales of JPY 3,116.0 billion, operating profit of JPY 43.5 billion, ordinary profit of JPY 57.0 billion, and profit attributable to owners of parent of JPY 33.5 billion or EPS of JPY 148.
MEDIPAL HOLDINGS CORPORATION engages in the wholesale of pharmaceutical products, cosmetics and daily miscellaneous goods. The Company operates in three segments. The Ethical Pharmaceutical Wholesale segment is involved in the wholesale of pharmaceutical products, medical equipment and test reagents, the distribution and planning of specialty drugs, the construction of medical material database and others. The Cosmetics, Daily Product and General Medicine Wholesale segment is engaged in the wholesale of cosmetics, daily miscellaneous goods and general pharmaceuticals. The Veterinary Medicine and Food Processing Raw Materials Wholesale segment is engaged in the wholesale of veterinary products, food additives and food raw materials. The Company is also involved in the provision of cleaning services, the management and operation of logistics centers, the provision of manpower dispatching services and others.
Medipal Holdings Corporation Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2017; Reaffirms Consolidated Earnings Guidance for the Year Ending March 31, 2018